Advertisement
YOU ARE HERE: LAT HomeCollectionsSangcya Drug
IN THE NEWS

Sangcya Drug

FEATURED ARTICLES
BUSINESS
November 3, 1998 | Davan Maharaj
The Food and Drug Administration is expected to announce approval today of a generic version of a drug used to improve the results of organ transplants. Menlo Park-based SangStat said the FDA will give it permission to market SangCya, a generic version of cyclosporine. Company executives said they plan to sell their product 20% cheaper than Neoral, the cyclosporine formulation produced by Swiss drug maker Novartis.
ARTICLES BY DATE
BUSINESS
November 3, 1998 | Davan Maharaj
The Food and Drug Administration is expected to announce approval today of a generic version of a drug used to improve the results of organ transplants. Menlo Park-based SangStat said the FDA will give it permission to market SangCya, a generic version of cyclosporine. Company executives said they plan to sell their product 20% cheaper than Neoral, the cyclosporine formulation produced by Swiss drug maker Novartis.
Los Angeles Times Articles
|